Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

On-admission Low-dose Colchicine in Addition to Atorvastatin to Reduce Inflammation in Acute Coronary Syndrome

NCT05250596 is registered in ClinicalTrials.gov with Azienda USL Toscana Centro as lead sponsor.

NCT NCT05250596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05250596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
On-admission Low-dose Colchicine in Addition to Atorvastatin to Reduce Inflammation in Acute Coronary Syndrome
Lead sponsor
Azienda USL Toscana Centro
Phase
Phase 2
Overall status
Completed
Start date
February 24, 2022
Completion date
May 30, 2024
Enrollment
182 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

non st segment elevation acute coronary syndrome